It seems that while both low dose and high dose CYC may have anti-tumor effects, low dose CYC does so through depletion of CD4+CD25+ T-cells and, thus, increased anti-tumor effect, while high dose CYC does so through alkylation and direct cytotoxicity [170]. Here, IL2RA is linked to neoplasm.